ozonated olive oil
Commercial- Indications
- Skin conditions, Wound healing
Company intelligence / Profile preview
Philogen has a robust clinical pipeline with multiple antibody-cytokine fusion products and small molecule radiotracers in various stages of clinical development. Lead programs include Nidlegy for melanoma and skin cancers in advanced trials; Fibromun for soft tissue sarcoma and other tumors; Darleukin for lung cancer; Dodekin for solid tumors; Dekavil for chronic inflammation; OncoCAIX and OncoFAP as diagnostic radiotracers. Several programs have reached phase II or III trials with registrational studies planned.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Philozon.